ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 101 filers reported holding ADICET BIO INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,000 | -12.5% | 5,102 | +60.6% | 0.00% | – |
| Q2 2023 | $8,000 | -20.0% | 3,176 | +85.0% | 0.00% | – |
| Q1 2023 | $10,000 | -67.7% | 1,717 | -51.2% | 0.00% | – |
| Q4 2022 | $31,000 | +520.0% | 3,515 | +873.7% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 361 | +118.8% | 0.00% | – |
| Q2 2022 | $2,000 | -93.8% | 165 | -89.6% | 0.00% | – |
| Q1 2022 | $32,000 | -52.2% | 1,583 | -58.9% | 0.00% | – |
| Q4 2021 | $67,000 | +191.3% | 3,851 | +32.2% | 0.00% | – |
| Q3 2021 | $23,000 | +27.8% | 2,912 | +69.6% | 0.00% | – |
| Q2 2021 | $18,000 | +63.6% | 1,717 | +119.0% | 0.00% | – |
| Q1 2021 | $11,000 | -15.4% | 784 | -16.0% | 0.00% | – |
| Q4 2020 | $13,000 | +30.0% | 933 | +5.3% | 0.00% | – |
| Q3 2020 | $10,000 | – | 886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |